Holen Sie sich die Stockscreener-App
4.37
0.46%
-0.02
Finanzdaten der Evoke Pharma Inc-Aktie (EVOK)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.55%
1.7355
|
1.676 | 1.5629 | 1.1314 | 0.8104 |
Operating Expenses
|
9.18%
3.2367
|
3.5639 | 3.1663 | 2.9158 | 2.9655 |
| Interest Income/Expense |
1.09%
0.1247
|
0.126 | 0.126 | 0.1247 | 0.1233 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
9.18%
3.2367
|
3.5639 | 3.1663 | 2.9158 | 2.9655 |
| Operating Income/Loss |
20.48%
-1.5012
|
-1.8879 | -1.6034 | -1.7844 | -2.1551 |
| Nonoperating Income/Loss |
20.99%
-0.0786
|
-0.0995 | -0.0905 | -0.0835 | -0.088 |
| Income/Loss From Continuing Operations Before Tax |
3.55%
1.7355
|
1.676 | 1.5629 | -1.8679 | -2.2431 |
| Income/Loss From Continuing Operations After Tax |
20.51%
-1.5798
|
-1.9874 | -1.6939 | -1.8679 | -2.2431 |
|
Net Income/Loss
|
20.51%
-1.5798
|
-1.9874 | -1.6939 | -1.8679 | -2.2431 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9.0821
|
- | 3.3431 | 3.3431 | 3.3431 |
| Diluted Average Shares |
9.0821
|
- | 3.3431 | 3.3431 | 3.3431 |
| Basic Earnings Per Share |
71.19%
-0.17
|
-0.59 | -0.51 | -0.56 | -0.67 |
| Diluted Earnings Per Share |
71.19%
-0.17
|
-0.59 | -0.51 | -0.56 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):